18.05.2022

Swiss TPH Awarded Four New Research Grants in Paediatric Health

Swiss TPH has been awarded four out of six new research grants from the Principal Investigator Initiative of the Botnar Research Centre for Child Health (BRCCH). The initiative... More...

02.05.2022

Legionellosis Cases Continue to Increase in Switzerland

The number of legionellosis cases in Switzerland has increased five-fold over the past 20 years. A study by the Swiss Tropical and Public Health Institute (Swiss TPH) published... More...

01.04.2022

New Swiss TPH Headquarters Opened in Allschwil

On Friday, 1 April 2022, the new headquarters of the Swiss Tropical and Public Health Institute (Swiss TPH) officially opened in the BaseLink site, an emerging life science cluster... More...

16.03.2022

Increasing Awareness of Noma – A Severe but Treatable Disease

There is very limited data on the incidence and prevalence of noma, which hinders better management and treatment of this devastating disease that mainly affects young and... More...

25.02.2022

Gut Microbiota Influences Treatment against Parasitic Worms

Almost a quarter of the world's population is at risk of helminth infections and available treatment options are limited. Therefore, a better understanding of why anti-parasitic... More...

16.02.2022

Farewell to Dr. Mwele Ntuli Malecela, Director of the Department of Control of Neglected Tropical Diseases at WHO

It is with great sadness that we learned about the passing of Dr. Mwele Ntuli Malecela, Director of Neglected Tropical Diseases at the World Health Organization (WHO). We have lost... More...

11.02.2022

Multi-Insecticide Resistant Malaria Vectors Remain Susceptible to Malathion Insecticide

Insecticide resistant mosquitoes are a growing concern in malaria control. A study conducted by Swiss TPH and partners raises hope that multi-resistant malaria vectors remain... More...

10.02.2022

ANTICOV: Clinical Trial for COVID-19 in Low-resource Settings to Test a New Drug Combination

The need for effective COVID-19 treatments remains particularly acute, especially in sub-Saharan Africa where access to vaccines is still extremely limited. The ANTICOV clinical... More...

08.02.2022

Altitude Positively Impacts Cardiovascular Health Peruvian Study Finds

People living in high altitudes are less likely to develop metabolic syndrome, a key indicator of cardiovascular health. A study published today in PLOS One investigated the... More...

03.02.2022

Analysis of 20 Years Finds Malaria Control in Young Children Saves Lives into Adulthood

Tanzanian study of 6,700 children over two decades highlights new insights into the long-term health benefits of bed nets. More...

02.02.2022

The Swiss TPH Travel Clinic Temporarily Moves Next Door

The Swiss Tropical and Public Health Institute (Swiss TPH) recently moved into its new headquarters in the Bachgraben area in Allschwil, canton Basel-Landschaft. The Swiss TPH... More...

17.12.2021

Assessing the Potential Health Impact of Omicron

Cases of SARS-CoV-2 variant Omicron are surging in numerous settings, with early evidence suggesting Omicron is more infectious than the Delta variant. It is not yet known,... More...

13.12.2021

Health Economics to Advance Sleeping Sickness Elimination

Global health decision-makers use frameworks to support them with creating strategies to meet global elimination targets for diseases, such as sleeping sickness. In a recent study... More...

03.12.2021

Elimination on the Horizon: Prevalence of Schistosomiasis, a Neglected Tropical Disease, Decreases by Nearly 60%

In a new study by the Swiss Tropical and Public Health Institute (Swiss TPH), researchers found that the prevalence of schistosomiasis among school-aged children decreased by... More...

30.11.2021

People from Low-Income Households Severely Affected by Pandemic

The COVCO-Basel study by the Swiss Tropical and Public Health Institute (Swiss TPH) has been investigating the health-related and societal effects of the COVID-19 pandemic for over... More...

30.11.2021

Promising Drug Combination Treatment Against Parasitic Worm Infections

In a Phase III clinical trial, researchers at Swiss TPH have successfully gathered encouraging data to demonstrate higher efficacy of co-administration of ivermectin-albendazole in... More...

16.11.2021

Clinical Trials Completed for a New Drug to Treat Parasitic Worm Infections in Infants

The Pediatric Praziquantel Consortium completed its pivotal clinical Phase III trial of arpraziquantel – a potential new treatment option for the estimated 50 million... More...

09.11.2021

A Decline in Air Pollution Levels in Europe Still Fall Short of WHO Guidelines, According to New Study

A new study by Swiss TPH used robust spatio-temporal methodology to show the reduction in air pollution across Europe from 2006-2019 and found that while exposure rates have... More...